Morgan Stanley Maintains Overweight on Elanco Animal Health, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright has maintained an Overweight rating on Elanco Animal Health (NYSE:ELAN) and increased the price target from $16 to $17.
February 27, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reaffirmed its Overweight rating on Elanco Animal Health and raised the price target from $16 to $17.
The increase in price target by a reputable analyst like Erin Wright from Morgan Stanley typically signals a positive outlook on the stock, suggesting potential upside. This could lead to increased investor confidence and a short-term rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100